Evidence map›Paper›PMID 28173821›Full record

ArticleVirology journal2017

Identification of influenza A nucleoprotein body domain residues essential for viral RNA expression expose antiviral target.

Alicia M Davis, Jose Ramirez, Laura L Newcomb

Open access · goldAbstract read
In one paragraph

Article in Virology journal, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.5field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 12 citations in OpenAlex.

  1. BIK polymorphism and proteasome regulation unveil host risk factor for severe influenza.Proceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  2. Article
  3. Review
  4. Article
  5. Review
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

Alicia M DavisDepartment of Biology, California State University San Bernardino, San Bernardino, CA, USA.
Jose RamirezDepartment of Biology, California State University San Bernardino, San Bernardino, CA, USA.
Laura L NewcombDepartment of Biology, California State University San Bernardino, San Bernardino, CA, USA. lnewcomb@csusb.edu.
California State University, San Bernardino · USTufts University · US

Funding

CSU San Bernardino Minority Access to Research CareersT34GM083883 · NIGMS · CALIFORNIA STATE UNIV SAN BERNARDINO · PI MCDOUGALL, SANDERS · 2009 to 2019
$3.0M
CSUSB RISE ProgramR25GM100829 · NIGMS · CALIFORNIA STATE UNIV SAN BERNARDINO · PI CRAWFORD, CYNTHIA A. · 2013 to 2017
$2.0M
Influenza nucleoprotein interactions and viral RNA synthesisSC3GM099559 · NIGMS · CALIFORNIA STATE UNIV SAN BERNARDINO · PI NEWCOMB, LAURA LYNN · 2012 to 2023
$866k
NIGMS NIH HHS R25 GM100829NIGMS NIH HHS SC3 GM099559NIGMS NIH HHS T34 GM083883
6 · The paper itself

Abstract

backgroundInfluenza A virus is controlled with yearly vaccination while emerging global pandemics are kept at bay with antiviral medications. Unfortunately, influenza A viruses have emerged resistance to approved influenza antivirals. Accordingly, there is an urgent need for novel antivirals to combat emerging influenza A viruses resistant to current treatments. Conserved viral proteins are ideal targets because conserved protein domains are present in most, if not all, influenza subtypes, and are presumed less prone to evolve viable resistant versions. The threat of an antiviral resistant influenza pandemic justifies our study to identify and characterize antiviral targets within influenza proteins that are highly conserved. Influenza A nucleoprotein (NP) is highly conserved and plays essential roles throughout the viral lifecycle, including viral RNA synthesis.

methodsUsing NP crystal structure, we targeted accessible amino acids for substitution. To characterize the NP proteins, reconstituted viral ribonucleoproteins (vRNPs) were expressed in 293 T cells, RNA was isolated, and reverse transcription - quantitative PCR (RT-qPCR) was employed to assess viral RNA expressed from reconstituted vRNPs. Location was confirmed using cellular fractionation and western blot, along with observation of NP-GFP fusion proteins. Nucleic acid binding, oligomerization, and vRNP formation, were each assessed with native gel electrophoresis.

resultsHere we report characterization of an accessible and conserved five amino acid region within the NP body domain that plays a redundant but essential role in viral RNA synthesis. Our data demonstrate substitutions in this domain did not alter NP localization, oligomerization, or ability to bind nucleic acids, yet resulted in a defect in viral RNA expression. To define this region further, single and double amino acid substitutions were constructed and investigated. All NP single substitutions were functional, suggesting redundancy, yet different combinations of two amino acid substitutions resulted in a significant defect in RNA expression, confirming these accessible amino acids in the NP body domain play an important role in viral RNA synthesis.

conclusionsThe identified conserved and accessible NP body domain represents a viable antiviral target to counter influenza replication and this research will contribute to the well-informed design of novel therapies to combat emerging influenza viruses.

Indexed as

Amino Acid SequenceAmino Acid SubstitutionAntiviral AgentsGene Expression Regulation, ViralHEK293 CellsHumansInfluenza A virusInfluenza, HumanMutationNucleocapsid ProteinsRibonucleoproteinsRNA-Binding ProteinsRNA, ViralStructure-Activity RelationshipTransfectionViral Core ProteinsAntiviral AgentsNP protein, Influenza A virusNucleocapsid ProteinsRibonucleoproteinsRNA-Binding ProteinsRNA, ViralViral Core ProteinsViral ProteinsInfluenzaNucleoproteinRNAVirus

Identifiers

PMID28173821
PMCPMC5294902
OpenAlexW2586129861

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.